Replies to post #1 on Aegerion Pharmaceuticals Inc (fka AEGR)

[surf1944]

7:05AM Aegerion Pharma holds Pre-NDA meeting with FDA for investigational lomitapide and is on track for NDA submission (AEGR) 16.91 : Co announces it concluded a pre-New Drug Application meeting with the FDA related to its investigational drug candidate, lomitapide, for the treatment of homozygous familial hypercholesterolemia. Following the meeting, the cp said it intends to proceed with its NDA submission as previously announced.